Kolbeck Roland Wilhelm
SEC insider (Form 3/4/5 filer). CIK 0002076327. Chief Scientific Officer at Aclaris Therapeutics, Inc. (ACRS). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 1, 2026. Located in WAYNE, PA.
Companies Kolbeck Roland Wilhelm has filed insider reports for
- Aclaris Therapeutics, Inc. (ACRS): Officer, Chief Scientific Officer
Kolbeck Roland Wilhelm
CIK: 0002076327
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Aclaris Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 1, 2026ACRS
Aclaris Therapeutics, Inc.
ExerciseDirect36.4K shares- - Aug 1, 2026ACRS
Aclaris Therapeutics, Inc.
Tax PaymentDirect12.4K shares at avg. $5.20$64K - Feb 2, 2026ACRS
Aclaris Therapeutics, Inc.
AwardDirectRestricted Stock Units
95.7K shares- - Feb 2, 2026ACRS
Aclaris Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
334.9K shares- - Aug 1, 2025ACRS
Aclaris Therapeutics, Inc.
AwardDirectRestricted Stock Units
145.5K shares- - Aug 1, 2025ACRS
Aclaris Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
510K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 1, 2026 | ACRS Aclaris Therapeutics, Inc. | Exercise | 36,375 | - | $0 | Direct |
| Aug 1, 2026 | ACRS Aclaris Therapeutics, Inc. | Tax Payment | 12,385 | $5.20 | $64,402 | Direct |
| Feb 2, 2026 | ACRS Aclaris Therapeutics, Inc. | Award Restricted Stock Units | 95,700 | - | - | Direct |
| Feb 2, 2026 | ACRS Aclaris Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 334,900 | - | - | Direct |
| Aug 1, 2025 | ACRS Aclaris Therapeutics, Inc. | Award Restricted Stock Units | 145,500 | - | - | Direct |
| Aug 1, 2025 | ACRS Aclaris Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 510,000 | - | - | Direct |
1-6 of 6 transactions